Prognostic Factors Associated with Curing in Patients with Breast Cancer: A Joint Frailty Model

Freshteh Osmani, Ebrahim Hajizadeh, Mohammad Esmaeil Akbari

Abstract


Background: Recurrent event data arise frequently in longitudinal medical studies. In many situations, there are a large portion of patients without any recurrences, manifesting the “zero‑inflated” nature of the data. Moreover, there often exists a terminal event which may be correlated with the recurrent events. The goal of this study is to extend the application of joint frailty model to identify the prognostic factors associated with curing in patients with breast cancer.

Methods: As a prospective study, medical records of women who had been attended to Cancer Research Center, Shahid Beheshti University of Medical Sciences from January 1998 to February 2016 were reviewed. Finally, after an initial review of medical records, 711 patients were included in the study and analyzed. A checklist that included items drawn from the demographic background of patients was provided in the study. Two joint frailty models for zero‑inflated recurrent events, combining a logistic model for “structural zero” status (Yes/No) and a joint frailty proportional hazards model for recurrent and terminal event times were performed to identify factors associated with BCS.

Results: The mean age of patients was 38.2 years. The numbers of subjects with 1, 2, 3, and 4 recurrent events were 392, 207, 97, and 15, respectively. The median follow‑up time was 6.87 years. There were 137 (19.2%) deaths from cancer during the follow‑up. Among the 574 patients who were censored, 418 had no tumor recurrence. Thus, there may exist a large portion of “cured” subjects. We can see that the radiation (OR = 6.02, CI = (3.87, 8.61)) and tumor size interaction with radiation (OR = 1.065, CI = (1.002–1.26)) were significant in the cure model (P < 0.05) which means that patients with smaller tumor sizes were more likely to be cured by radiation therapy.

Conclusions: Our proposed models can help investigators to evaluate which treatment will result in a higher fraction of cured subjects. This is usually an important research question in biomedical studies.


Keywords


Breast neoplasm; cure model; frailty; survival analysis

Full Text:

PDF

References


Cook RJ, Lawless J. The Statistical Analysis of Recurrent

Events. New York: Springer Science & Business Media; 2007.

Osmani F, Hajizadeh E, Mansouri P. Use of smoothing methods

for estimating the coefficients of time dependent rate models in

survival analysis and its application in psoriasis disease. Iran J

Epidemiol 2016;15;12:36‑46.

Liu L, Huang X. Joint analysis of correlated repeated measures

and recurrent events processes in the presence of death, with

application to a study on acquired immune deficiency syndrome.

J R Stat Soc 2009;58:65‑81.

Cancer Genome Atlas Network. Comprehensive molecular

portraits of human breast tumors. Nature 2012;490:61‑70.

Montagna E, Bagnardi V, Rotmensz N, Viale G, Renne G,

Cancello G, et al. Breast cancer subtypes and outcome after local

and regional relapse. Ann Oncol 2012;23:324‑31.

O’Shaughnessy J. Extending survival with chemotherapy in

metastatic breast cancer. Oncologist 2005;10(Suppl 3):20‑9.

Prentice RL, Williams BJ, Peterson AV. On the regression

analysis of multivariate failure time data. Biometrika

;68:373‑9.

Andersen PK, Gill RD. Cox’s regression model for counting

processes: A large sample study. Ann Stat 1982;10:1100‑20.

Zeng D, Lin DY. Efficient estimation of semiparametric

transformation models for counting processes. Biometrika

;93:627‑40.

Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate

incomplete failure time data by modeling marginal distributions.

J Am Stat Assoc 1989;84:1065‑73.

Osmani F, Hajizadeh E, Mansouri P. Kernel and regression

spline smoothing techniques to estimate coefficient in rates

model and its application in psoriasis. Med J Islam Repub Iran

;33:546‑50.

Huang CY, Wang MC. Joint modeling and estimation for

recurrent event processes and failure time data. J Am Stat Assoc

;99:1153‑65.

Ye Y, Kalbfleisch JD, Schaubel DE. Semiparametric analysis

of correlated recurrent and terminal events. Biometrics

;63:78‑87.

Cook RJ, Lawless JF, Lakhal‑Chaieb L, Lee KA. Robust

estimation of mean functions and treatment effects for recurrent

events under event‑dependent censoring and termination:

Application to skeletal complications in cancer metastatic to

bone. J Am Statt Assoc 2009;104:60‑75.

Park HS, Kim S, Kim K, Yoo H, Chae BJ, Bae JS, et al. Pattern

of distant recurrence according to the molecular subtypes

in Korean women with breast cancer. World J Surg Oncol

;10:4.

Kulkarni SV, Mishra GA, Dusane RR. Determinants of

compliance to breast cancer screening and referral in low

socio‑economic regions of urban India. Int J Prev Med

;10:84.

Wu X, Baig A, Kasymjanova G, Kafi K, Holcroft C, Mekouar H,

et al. Pattern of local recurrence and distant metastasis in breast

cancer by molecular subtype. Cureus 2016;8:e924.

Dignam JJ, Dukic V, Anderson SJ, Mamounas EP,

Wickerham DL, Wolmark N. Hazard of recurrence and adjuvant

treatment effects over time in lymph node‑negative breast cancer.

Breast Cancer Res Treat 2009;116:595‑602.

Ghaffari M, Rad TN, Mohammadi S, Rakhshanderou S. Effect

of an intervention on the breast cancer screening behavior in

women: Application of integrated behavioral model. Int J Prev

Med 2018;9:99.

Rondeau V, Mazroui Y, Gonzalez JR. frailtypack: An R package

for the analysis of correlated survival data with frailty models

using penalized likelihood estimation or parametrical estimation.

J Stat Softw 2012;47:1‑28.

Osmani F, Hajizadeh E, Rasekhi A, Akbari ME. Multivariate

joint frailty models for modeling multiple recurrent events and

its application in breast cancer. RJMS 2019;25:71‑9.

Osmani F, Hajizadeh E, Rasekhi A. Association between multiple

recurrent events with multivariate modeling: A retrospective

cohort study. J Res Health Sci 2018;18:e00433.

Shirzadi A, Mahmoodzadeh H, Qorbani M. Assessment of

sentinel lymph node biopsy after neoadjuvant chemotherapy for

breast cancer in two subgroups: Initially node negative and node

positive converted to node negative – A systemic review and

meta‑analysis. J Res Med Sci 2019;24:18.

Osmani F, Hajizadeh E, Rasekhi A, Akbari ME. Analyzing

relationship between local and metastasis relapses with survival

of patients with breast cancer: A study using joint frailty model.

Int J Cancer Manag 2018;11:e81783.

Tanis E, van de Velde CJ, Bartelink H, van de Vijver MJ,

Putter H, van der Hage JA. Locoregional recurrence after

breast‑conserving therapy remains an independent prognostic

factor even after an event free interval of 10 years in early stage

breast cancer. Eur J Cancer 2012;48:1751‑6.

Osmani F, Hajizadeh E, Mansoori P. Estimation of seasonal effect

on the psoriasis recurrence using time dependent coefficient rates

model for recurrent events. J Dermatol Cosmet 2015;6:23‑30.

Osmani F, Hajizadeh E, Rasekhi A, Akbari M. Multivariate

frailty modeling in joint analyzing of recurrent events with

terminal event and its application in medical data. IRJE

;15:162‑71.